"Smoke-free Generation" Plan in UK

Regulations by 2FIRSTS.ai
Dec.11.2023
"Smoke-free Generation" Plan in UK
The UK government consults local councils on the "Smokefree Generation" plan to impose strict restrictions on e-cigarette products.

According to information from Bexton Advertising, the UK central government is currently seeking opinions from local authorities on a new plan called "Smoke-Free Generation". This new plan proposes strict limitations on e-cigarette products and a ban on selling tobacco products to individuals aged 14 and above.

 

The Derbyshire County Council has expressed support for this new initiative and has recommended banning the sale of sweet-flavored e-cigarettes, including marshmallow, bubblegum, caramel, ice cream, soda, and fruity flavors. The central government's plan aims to prohibit the sale of tobacco products to individuals born on or after January 1, 2009.

 

This legislation will effectively prevent children aged 14 or younger from legally purchasing tobacco products - raising the minimum smoking age by one year annually until it applies to the entire population.

 

Derbyshire County Council is urging the government to ban e-cigarettes with cotton candy, bubble gum, caramel, ice cream, and soda flavors. Furthermore, the government plans to restrict the variety of e-cigarette flavors, introduce standardized plain packaging, and limit the sale of disposable e-cigarettes. The local authorities will have the power to impose fines on those who sell tobacco products and e-cigarettes to underage residents.

 

According to Derbyshire County Council, approximately 14% of adults in Derbyshire, which accounts for around 90,000 people, smoke as of 2022. This figure is higher than the national average of 12.7%. Additionally, despite a decline, 11.8% of adults in Derbyshire still smoke during pregnancy, surpassing the national average of 9.1%.

 

Carol Hart, the chief of the health department at Derby County Council, has issued an official response detailing the importance of clear and accurate regulations on e-cigarettes. These regulations will enable enforcement personnel to remove non-compliant products from shelves while ensuring that flavored options are still available for smokers who wish to quit.

 

This aligns with the approach taken by New Zealand, where regulations stipulate that e-cigarettes must be described by their generic names as specified by law, such as tobacco or berry, and they cannot be referred to as "blueberry pancakes".

 

This could reduce the appeal of e-cigarettes to young people while still providing options for adult smokers. Imposing restrictions on ingredients or flavors would require product testing before implementation, which would significantly increase both time and costs.

 

It is recommended to prohibit the use of flavors in products that are not suitable for the aforementioned categories such as tobacco, mint, menthol, and fruit. Flavors like marshmallow, bubblegum, caramel, ice cream, and soda should not be included, and additional research is needed to determine the inclusion of fruit flavors.

 

Taste is not the sole factor influencing the initiation and continued use of e-cigarettes. Nicotine levels, marketing and advertising, design, peer influence, pricing, availability, and accessibility are also some of the factors.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product|PMI Expands High-Strength Nicotine Pouch Portfolio With Zyn 16.5mg
Product|PMI Expands High-Strength Nicotine Pouch Portfolio With Zyn 16.5mg
According to Better Retailing, Philip Morris International (PMI) has launched Zyn Menthol Ice 16.5mg in the UK, marking the highest-strength nicotine pouch in the Zyn range to date. The eucalyptus- and menthol-flavored product is now available through PMI Open and will begin rolling out to wholesale channels from the end of May.
PMI
May.28
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
China Tobacco Yunnan Patent Describes Cigar Flavor Granules With Encapsulation Rate Above 77%
China Tobacco Yunnan Patent Describes Cigar Flavor Granules With Encapsulation Rate Above 77%
According to public records from China’s National Intellectual Property Administration, a patent application filed by China Tobacco Yunnan Industrial Co., Ltd. for “cigar flavor granules” was published on May 12, 2026. The filing proposes purifying an ethanol extract of cigar tobacco leaves using LX-8 macroporous resin, followed by encapsulation with maltodextrin and sucrose fatty acid ester to improve smoking comfort, reduce dryness and enhance aroma release stability in reconstituted tobacco.
Jun.10
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
Philip Morris Japan announced on April 23 at a product briefing that ZYN by IQOS, an oral tobacco pouch previously launched in selected areas, will expand sales in Tokyo. The company said the product will be released progressively from May 11 through IQOS shops, Lawson and other outlets in the city. The launch will include four flavors, each offered in Low and Medium intensity levels, for a total of eight products.
Apr.27 by 2FIRSTS.ai
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18